November is Diabetes Awareness Month. For those living with diabetes, New York-Presbyterian Hospital offers expert care with multidisciplinary depth in specialties such as endocrinology and metabolic surgery. This page contains a webcast about medical and surgical treatments for Type 2 diabetes as well as information on the Hospital's metabolic surgery and weight loss programs.

As you read this, billions of synapses lying between the cells of your brain are using complex chemical signals to pass information from one neuron to the next. It's a process crucial to healthy brain function as well as drug development, drug addiction and neurological disease, and researchers at Yale University School of Medicine-Howard Hughes Medical Institute and Weill Cornell Medical College believe they now have a better understanding of how synaptic transmission works.

A snippet of protein that sits on top of healthy prostate cells is often lost as the cell morphs into a potentially life-threatening cancer. The protein, known as neutral endopeptidase (NEP), is inactive in about half of all prostate cancers.

A specialist in the state-of-the-art diagnosis and treatment of gynecologic cancer, Dr. Thomas Herzog has been named Director of the Division of Gynecologic Oncology in the Department of Obstetrics and Gynecology at NewYork-Presbyterian Hospital/Columbia University Medical Center. He has also been appointed Professor of Obstetrics and Gynecology at Columbia University College of Physician and Surgeons. Dr. Herzog joined NewYork-Presbyterian/Columbia from Washington University School of Medicine in St. Louis, where he conducted extensive research in the underlying causes and mechanisms of gynecologic cancer.

For the first time a team of researchers led by the University of Minnesota and Weill Cornell Medical College has determined the complete genome sequence of Cryptosporidium, a common diarrhea-causing parasite that can lurk in drinking water. The finding has been published in the March 25 issue of the electronic journal Science Express, to be followed by publication in April in the print version of Science.

Hispanic men can expect the same success rate for surgical prostate cancer treatment as non-Hispanic white men, according to a new study by NewYork-Presbyterian Hospital/The Allen Pavilion published in the November Journal of Urology. The study, which is the largest of its kind, also found that Hispanic men presented with more advanced disease than their white counterparts. Prostate cancer is the most commonly diagnosed cancer and the second leading cause of cancer death among Hispanic-American men.

A new freezing treatment offers relief to patients with peripheral vascular disease (PVD), a painful condition in which plaque buildup narrows the arteries. In a first for Manhattan, interventional radiologists at NewYork-Presbyterian Hospital/Columbia have successfully treated patients using a new enhancement to traditional angioplasty that freezes and breaks up artery plaque.

Thanks to bioinformatics researchers at Weill Cornell Medical College, cell biologists around the globe will soon have a powerful new tool to model complex biochemical processes within the cell, uploading and manipulating new data as they team up with research partners via the Internet.